A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Conditions:   Advanced Solid Tumors;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Small Cell Lung Cancer;   Diffuse Large B Cell Lymphoma;   Epithelial Ovarian Cancer
Intervention:   Biological: MGD013
Sponsor:   MacroGenics
Not yet recruiting - verified July 2017

http://ift.tt/2vtYP01